GSK3008348
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK3008348, covering 2017-05-01 to 2019-08-12. Get the full timeline:
Most recent: Clinical Trial Update: Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging [Phase 1]